These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37985503)

  • 21. Swallowing after transoral surgery for oropharyngeal cancer: comparison with primary chemoradiotherapy outcomes.
    Dawe N; O'Hara J
    Curr Opin Otolaryngol Head Neck Surg; 2017 Apr; 25(2):101-107. PubMed ID: 28106661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor oral intake causes enteral nutrition dependency after concomitant chemoradiotherapy for pharyngeal cancers.
    Ishii R; Kato K; Ogawa T; Sato T; Nakanome A; Ohkoshi A; Kawamoto-Hirano A; Shirakura M; Hidaka H; Katori Y
    Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1607-1611. PubMed ID: 29610959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer.
    Szuecs M; Kuhnt T; Punke C; Witt G; Klautke G; Kramp B; Hildebrandt G
    J Radiat Res; 2015 Jan; 56(1):159-68. PubMed ID: 25348250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic swallowing disorders may be present in individuals with laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.
    Álvarez-Marcos C; Benito AV; Fernández AG; Pedregal-Mallo D; Rodríguez PS; Rabanal LS; Llorente JL; López F; Rodrigo JP
    Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):995-1001. PubMed ID: 33963434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How does radiotherapy impact swallowing function in nasopharynx and oropharynx cancer? Short-term results of a prospective study.
    Ursino S; Seccia V; Cocuzza P; Ferrazza P; Briganti T; Matteucci F; Fatigante L; Giusti P; Grosso M; Locantore L; Morganti R; Nacci A; Sellari Franceschini S; Paiar F; Caramella D; Fattori B
    Acta Otorhinolaryngol Ital; 2016 Jun; 36(3):174-84. PubMed ID: 27070541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
    Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
    Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
    Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
    Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swallowing-related quality of life after head and neck cancer treatment.
    Gillespie MB; Brodsky MB; Day TA; Lee FS; Martin-Harris B
    Laryngoscope; 2004 Aug; 114(8):1362-7. PubMed ID: 15280708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electromyography of the inferior constrictor and cricopharyngeal muscles during swallowing.
    Elidan J; Shochina M; Gonen B; Gay I
    Ann Otol Rhinol Laryngol; 1990 Jun; 99(6 Pt 1):466-9. PubMed ID: 2350131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manometry and electromyography of the pharyngeal muscles in patients with dysphagia.
    Elidan J; Shochina M; Gonen B; Gay I
    Arch Otolaryngol Head Neck Surg; 1990 Aug; 116(8):910-3. PubMed ID: 2378715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
    Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
    Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary treatment of carcinoma of oropharynx and hypopharynx: principles and EORTC studies.
    Snow GB
    Sonderb Strahlenther Onkol; 1987; 81():127-34. PubMed ID: 3547724
    [No Abstract]   [Full Text] [Related]  

  • 36. [New Combination Therapy to Improve the Functional Preservation Rate of the Larynx in Laryngeal, Oropharyngeal, and Hypopharyngeal Cancers].
    Furusaka T
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1141-7. PubMed ID: 26489542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
    Maggiore RJ; Curran EK; Witt ME; Haraf DJ; Vokes EE; Cohen EE
    J Geriatr Oncol; 2013 Oct; 4(4):327-33. PubMed ID: 24472475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transoral laser microsurgery ± adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes.
    O'Hara J; Cosway B; Muirhead C; Leonard N; Goff D; Patterson J
    Head Neck; 2015 Oct; 37(10):1488-94. PubMed ID: 24891273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Computerized manometry and deglutition after pharyngolaryngeal tumor resections].
    Walther EK; Herberhold C
    Laryngorhinootologie; 1993 Feb; 72(2):67-72. PubMed ID: 8461100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased short- and long-term swallowing problems with altered radiotherapy dosing used in an organ-sparing protocol for advanced pharyngeal carcinoma.
    Smith RV; Goldman SY; Beitler JJ; Wadler SS
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):831-6. PubMed ID: 15262759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.